Phase Ib Clinical Study on the Safety, the Tolerability, the Pharmacokinetics and the Efficacy of ScTIL Injection (Gene Modified Tumor Infiltrating Lymphocytes) Alone and in Combination With B Lymphocyte Adjuvant in the Treatment of Digestive System Malignant Solid Tumors

NCT05730361 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
48
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Peking University